SCHEMBL22148773

SCHEMBL22148773

c1ccc(-c2cc(-c3ccccc3)nc(-c3cccc(-c4c(-n5c6ccccc6c6ccccc65)c(-n5c6ccccc6c6ccccc65)nc(-n5c6ccccc6c6ccccc65)c4-n4c5ccccc5c5ccccc54)c3)c2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.36
MEN1 O00255 6/20 0.34
KMT2A Q03164 6/20 0.34
RAB9A P51151 1/20 0.34
ACHE P22303 1/20 0.33
LMNA P02545 5/20 0.33
KDM4E B2RXH2 5/20 0.33
ALDH1A1 P00352 4/20 0.33
HPGD P15428 4/20 0.33
MAPT P10636 3/20 0.33
NPC1 O15118 1/20 0.33
POLB P06746 1/20 0.33
GAA P10253 1/20 0.33
TSHR P16473 1/20 0.33
ALOX12 P18054 1/20 0.33
MAPK1 P28482 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
DHODH Q02127 1/20 0.33
L3MBTL1 Q9Y468 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22148772 0.96 KMT2A (0.35) CYP19A1MEN1KMT2ARAB9AACHE
SCHEMBL22148511 0.92 CYP19A1 (0.38) CYP19A1MEN1KMT2AACHELMNA
SCHEMBL22148510 0.92 CYP19A1 (0.38) CYP19A1MEN1KMT2AACHELMNA
SCHEMBL21889491 0.91 CYP19A1 (0.39) CYP19A1MEN1KMT2ARAB9AACHE
SCHEMBL21889508 0.91 ACHE (0.37) CYP19A1MEN1KMT2ARAB9AACHE
SCHEMBL22148533 0.90 MEN1 (0.42) MEN1KMT2AACHELMNAKDM4E
SCHEMBL30339202 0.89 TSPO (0.36) CYP19A1MEN1KMT2AACHELMNA
SCHEMBL30338985 0.89 TSPO (0.36) CYP19A1MEN1KMT2AACHELMNA
SCHEMBL22148774 0.88 MEN1 (0.42) MEN1KMT2AACHELMNAKDM4E
SCHEMBL23223066 0.87 CYP19A1 (0.36) CYP19A1MEN1KMT2ARAB9AACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200203622-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX, INC. (JP) 2020-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200203622-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES NDUFV3, NDUFV2, CRY2 CYP19A1 457/4885MEN1 2193/4885KMT2A 4367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.